Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

In vitro effect of glucocorticoids on nasal polyps.

Valera F, Brassesco MS, Castro-Gamero AM, Cortez MA, Queiroz RG, Tone LG, Anselmo-Lima WT.

Braz J Otorhinolaryngol. 2011 Sep-Oct;77(5):605-10. English, Portuguese.

2.

Suppression of inflammatory cytokine secretion by an NF-ĸB inhibitor DHMEQ in nasal polyps fibroblasts.

Valera FC, Umezawa K, Brassesco MS, Castro-Gamero AM, Queiroz RG, Scrideli CA, Tone LG, Anselmo-Lima WT.

Cell Physiol Biochem. 2012;30(1):13-22. doi: 10.1159/000339042. Epub 2012 Jun 5.

PMID:
22759952
3.

Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling.

Silvestri M, Sabatini F, Scarso L, Cordone A, Dasic G, Rossi GA.

Int Arch Allergy Immunol. 2002 May;128(1):51-8.

PMID:
12037401
4.

TNF-alpha upregulates VCAM-1 and NF-kappaB in fibroblasts from nasal polyps.

Ohori J, Ushikai M, Sun D, Nishimoto K, Sagara Y, Fukuiwa T, Matsune S, Kurono Y.

Auris Nasus Larynx. 2007 Jun;34(2):177-83. Epub 2006 Aug 24.

PMID:
16934424
5.

IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration.

Yoshifuku K, Matsune S, Ohori J, Sagara Y, Fukuiwa T, Kurono Y.

Rhinology. 2007 Sep;45(3):235-41.

PMID:
17956026
6.

Suppression of matrix metalloproteinase production from nasal fibroblasts by fluticasone propionate in vitro.

Namba M, Asano K, Kanai K, Kyo Y, Watanabe S, Hisamitsu T, Suzaki H.

Acta Otolaryngol. 2004 Oct;124(8):964-9.

PMID:
15513534
7.

Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaB.

Baouz S, Giron-Michel J, Azzarone B, Giuliani M, Cagnoni F, Olsson S, Testi R, Gabbiani G, Canonica GW.

Int Immunol. 2005 Nov;17(11):1473-81. Epub 2005 Oct 6.

8.
9.

GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone.

Hamilos DL, Leung DY, Muro S, Kahn AM, Hamilos SS, Thawley SE, Hamid QA.

J Allergy Clin Immunol. 2001 Jul;108(1):59-68.

PMID:
11447383
10.
12.

Inhibitory effects of casticin on migration of eosinophil and expression of chemokines and adhesion molecules in A549 lung epithelial cells via NF-κB inactivation.

Koh DJ, Ahn HS, Chung HS, Lee H, Kim Y, Lee JY, Kim DG, Hong M, Shin M, Bae H.

J Ethnopharmacol. 2011 Jul 14;136(3):399-405. doi: 10.1016/j.jep.2011.01.014. Epub 2011 Jan 18.

PMID:
21251967
13.

Fluticasone propionate and mometasone furoate have equivalent transcriptional potencies.

Roumestan C, Henriquet C, Bousquet J, Mathieu M.

Clin Exp Allergy. 2003 Jul;33(7):895-901.

PMID:
12859444
14.

Do corticosteroids induce apoptosis in nasal polyp inflammatory cells? In vivo and in vitro studies.

Saunders MW, Wheatley AH, George SJ, Lai T, Birchall MA.

Laryngoscope. 1999 May;109(5):785-90.

PMID:
10334231
15.

Tripterine inhibits the expression of adhesion molecules in activated endothelial cells.

Zhang DH, Marconi A, Xu LM, Yang CX, Sun GW, Feng XL, Ling CQ, Qin WZ, Uzan G, d'Alessio P.

J Leukoc Biol. 2006 Aug;80(2):309-19. Epub 2006 Jun 12.

16.

4-O-methylgallic acid down-regulates endothelial adhesion molecule expression by inhibiting NF-kappaB-DNA-binding activity.

Lee G, Na HJ, Namkoong S, Jeong Kwon H, Han S, Ha KS, Kwon YG, Lee H, Kim YM.

Eur J Pharmacol. 2006 Dec 3;551(1-3):143-51. Epub 2006 Sep 8.

PMID:
17027748
19.

Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment.

Valera FC, Queiroz R, Scrideli C, Tone LG, Anselmo-Lima WT.

Clin Exp Allergy. 2009 Jan;39(1):81-8. doi: 10.1111/j.1365-2222.2008.03144.x. Epub 2008 Nov 26.

PMID:
19068102
Items per page

Supplemental Content

Write to the Help Desk